Summary The accurate determination of exposure to environmental tobacco smoke is notoriously difficult. There have been to date two approaches to determining this exposure in the study of association of passive smoking and lung cancer: the biochemical approach, using cotinine in the main as a marker, and the epidemiological approach. Typically results of the former have yielded much lower relative risk than the latter, and have tended to be ignored in favour of the latter, although there has been considerable debate as to the logical basis for this. We settle this question by showing that, using the epidemiologically based meta-analysis technique of Wald et al. (1986), and misclassification models in the EPA Draft Review (1990), one arrives using all current studies at a result which is virtually identical with the biochemically-based conclusions of Darby and Pike (1988) Individual studies usually report overall relative risks or odds ratios and assess whether these are significantly raised from unity: that is, whether there is a significantly increased risk of lung cancer associated with ETS. In most individual studies, relative risks have not been significantly raised, but this could be due to the small size of the studies; and over the past 5 years there have been various evaluations using 'meta-analysis' of the overall risk of lung cancer following exposure to ETS. The two best known are the NRC Report (1986) and the paper by Wald et al. (1986). There are marked similarities in their evaluations, in that both calculate a 'combined relative risk', estimate the extent of bias due to differential misclassification of smokers and background exposure problems, and evaluate significance from the confidence levels established from the meta-analysis adjusted for misclassification, as in Sections 3 and 4 below. The EPA Draft Review (1990) and the recent review paper by Repace and Lowry (1990) also follow this pattern. These meta-analyses typically show a combined excess risk of around 0.3-0.5 for exposure to such spousal smoking, but this has been criticised largely because of the difficulties in accurate determination of exposure status (Lee, 1988; Uberla, 1987) .
Exposure to 'passive smoking', or environmental tobacco smoke (ETS) is far from easy to measure accurately (Lee, 1988) , since it is not a direct consequence of actions of the 'exposed' subjects. This means that standard research methods have been particularly difficult to use in considering the level of association between ETS and occurrence of diseases, even when strong levels of association have been reported between active smoking and those diseases.
In the 1970's it was accepted that either the levels of exposure or the types of exposure to ETS were such that no significant association between ETS and lung cancer existed. In the last decade, however, there have been well over 20 published epidemiological studies which have sought to investigate the association between exposure to ETS and lung cancer. This epidemiological approach (see Sections 3, 4) categorises exposure to ETS in terms of the smoking of spouses (except for Kabat, 1990 who uses home exposure) when the subject evaluated is a never-smoker, and then adjusts for now well-established differential sampling biases. The outcome assessed in these papers is usually occurrence of general lung cancer, although several concentrate on or are dominated by one specific form of this disease (e.g. Trichopoulos et al. (1981, 1983) , who exclude adenocarcinoma, or Garfinkel (1985) whose results conversely are dominated by adenocarcinoma); but in general all types are considered.
Individual studies usually report overall relative risks or odds ratios and assess whether these are significantly raised from unity: that is, whether there is a significantly increased risk of lung cancer associated with ETS. In most individual studies, relative risks have not been significantly raised, but this could be due to the small size of the studies; and over the past 5 years there have been various evaluations using 'meta-analysis' of the overall risk of lung cancer following exposure to ETS. The two best known are the NRC Report (1986) and the paper by Wald et al. (1986) . There are marked similarities in their evaluations, in that both calculate a 'combined relative risk', estimate the extent of bias due to differential misclassification of smokers and background exposure problems, and evaluate significance from the confidence levels established from the meta-analysis adjusted for misclassification, as in Sections 3 and 4 below. The EPA Draft Review (1990) and the recent review paper by Repace and Lowry (1990) also follow this pattern. These meta-analyses typically show a combined excess risk of around 0.3-0.5 for exposure to such spousal smoking, but this has been criticised largely because of the difficulties in accurate determination of exposure status (Lee, 1988; Uberla, 1987) .
Simultaneously with the epidemiological studies, there has been a second and more direct approach to the problem of estimating levels of ETS exposure. The biochemical marker approach (see Section 2) attempts to measure takeup of nicotine derivatives, converts this to a 'cigarette equivalent' figure, and estimates a relative risk based on extrapolating the observed relative risk for active smoking.
Both the NRC Report (1986) and the EPA Draft Review (1990) review this biochemical 'cigarette-equivalent' approach, as does the review by Repace and Lowry (1990) . All find substantially lower results for the excess risk using this biochemical marker method, of the order of 0.03-0.10, and this is supported by a similar model-based approach of Darby and Pike (1988) .
This discrepancy clearly presents some methodological problems as to which level of association is correct, and by implication which approach (if either) to determining exposure is reliable. This has engendered considerable recent and rather inconclusive debate (see Darby & Pike, 1988; Wald et al., 1990; 1991a,b; Lee et al., 1991a,b) .
Since the reviews cited above have been carried out, results from a number of further epidemiological studies have been published. These enable a revised calculation of the risk from the epidemiological data, and one purpose of our paper is to carry out such a revised assessment.
We show that after the now-standard 'Wald adjustment' for differential misclassification, the two methods can be reconciled to provide an estimate of the relative risk of lung cancer associated with exposure to ETS, with a best current estimate of around 1.07.
The conduct of the meta-analysis itself raises a number of questions which are important in the use of this increasingly popular tool for combining otherwise small and insignificant studies, and these are discussed in relation to establishing this estimate and its significance level.
2. Cotinine, exposure to ETS and 'cigarette equivalents' Cotinine is a metabolite of nicotine which is widely used as a marker of exposure to tobacco smoke.
The NRC Report (1986, p. 226) states that 'urinary cotinine is at present the best marker of tobacco smoke intake for passive smoking dosimetry'. Darby and Pike (1988) affirm that cotinine has proved 'most useful in assessing average daily exposure to tobacco smoke' and Repace and Lowry (1990) Suppose the ratio of cotinine observed in the population exposed to ETS when compared to cotinine observed in active smokers is p. Since it has been estimated (cf Darby and Pike (1988) , NRC Report (1986) ) that the half life of cotinine is about 50% longer in active smokers than in non-smokers, if we assume that the continine ratio is directly linearly linked to the ratio of excess risks, we get p = 1.5 EETs/EA There are then two parameters which must be estimated to conclude this argument, namely p and EETS, and both have been subjects of some debate.
The data of Wald and Ritchie (1984) has been used by, for example, Wald et al. (1986) to provide an estimate of p of around 1% for the ratio of cotinine observed in the population exposed to ETS when compared to cotinine observed in active smokers, whilst Jarvis et al. (1984) provide an estimate of the ratio p of around 0.6% to 0.8%. Lee (1991a) argues that the higher figure of 1% is biased upwards by possible inclusion of smokers; Wald et al. (199la) argue that the lower value of 0.6% to 0.8% is invalid due to problems of definition and censoring of high values.
However, assuming that this range of 0.6-1% is at least reasonable gives a value of EETS/EA of 0.4% to 0.66%.
The excess risk EA for active female smokers is variously taken as seven (Wald et al., (1986) and the NRC Report (1986)), or 11 (EPA Draft Review (1990) ). Wald et al. (199 1a) argue that since the level of active smoking is by the husband, the value of 11 for the excess risk of currently active male smoking is relevant, although again Lee (199 ib) disputes this, and suggests that 7.3 is appropriate, being the excess for ever-smoking males rather than currently active smokers.
The lowest of these combinations of estimates yield a value of RRETS= 1.028, whilst the highest estimates give RRETS = 1.08 for the relative risk of those exposed to environmental tobacco smoke.
This range is also supported by other approaches using cotinine which have been used to evaluate relative risk levels. Darby and Pike (1988) , in a detailed model of lung cancer evolution, show that, if the dosage taken up by those exposed to ETS is equivalent on average to active smoking of 0.1 cigarettes per day, then the relative risk for those exposed from age 20 to age 65 extrapolated from active smoking estimates will be 1.06 (see Table III of Darby and Pike (1988) The value of 0.1 'cigarette equivalents' here is at the high end of the range put forward by Darby and Pike (1988, p. 830), although it is at the low end of the range suggested by Vutuc (1984) . Repace and Lowry (1990, p. 29) assert as reasonable an assumption of uptake of nicotine by those exposed to ETS of 0.5-1% of the uptake by active smokers. This gives effectively the same level of 'cigarette equivalent' as that used by Darby and Pike (1988 Yusuf et al. (1985) , and the technique has been adopted in the NRC Report (1986) and the EPA Draft Review (1990) .
Since the NRC Report (1986) Kabat (1990) , Kalandidi et al. (1990) , Liu et al. (1991) and Fontham et al. (1991) have appeared since the preparation of the EPA Draft Review (1990) . Table I gives the relative risks and associated confidence intervals, calculated (except for Varela (1987) ) using the logit method, of all case-control studies on females published to date. (The numbers of males who are never-smokers and who contract lung cancer constitute a very small study population. Addition of those investigations which report on males does not materially change the results in Table I ). The Varela (1987) (Tweedie et al. (submitted) ) that the true extent of this misclassification bias is actually somewhat higher than this, and Lee (1988) has an extensive discussion of the basis for establishing an appropriate value. Lee (199la) , using the ratio of relative risks for ETS and active smokers, asserts that a more extensive misclassification has also taken place, although Wald et al. (199la, b) Suppose levels of cotinine are in principle known for nonsmokers exposed to ETS (defined as those with smoking spouses) and for non-smokers supposedly unexposed.
If 6 is the level of cotinine in the supposedly unexposed individuals, if a is the level in supposed non-smokers exposed to ETS, and if RRo is the observed relative risk for exposure to ETS as found from epidemiological studies, then one may find the true relative risk RRETS = 1 + a from solving RRo = (1 + a)/(1 + 6) Wald et al. (1986) and the NRC Report (1986), based on data of Wald and Ritchie (1984) , adopted the ratio (ai/ 6) = 3.0 in carrying out this analysis. The value of 3.0 is supported to a certain extent in other literature (see 4-28 of the EPA Draft Review (1990) , which justifies and adopts the value of 3.0, and also Lam (1985) on such an argument; and these, conversely, provide much of the increased overall relative risk.
A separate analysis of all US studies in Table I gives an estimated relative risk of 1.10 with a 95% CI of (0.95, 1.27).
This might be a more conservative and safer estimate of the level of association of ETS and lung cancer under western conditions, although applying the Wald-EPA correction of 0.12 to this value actually reduces it below unity.
It has also been suggested that inclusion of the Varela (1987) results, because they are only in thesis form and relatively hard to access, is invalid. This seems an extremely dangerous approach to meta-analysis. We have included the results of Geng et al. (1988) despite the poor information of the study available; the Varela (1987) study is (once located) particularly well-documented in comparison to most published studies, as it must be to be reviewed by thesis examiners.
The real danger with any meta-analysis is the spurious inflation of results due to omission of unpublished negative results (see Chalmers & Buyse, 1988) . One must include, at least initially, all available studies unless there is clear and documented reason to omit them, and the analysis above does this.
Use of adjusted estimates There are many potential confounders of the relationship between ETS and lung cancer: age, diet, occupation, have all been suggested as possible variables for which results should be adjusted. Use of such adjusted estimates in a metaanalysis is usually not possible, since it confuses the relative risks being combined unless the covariates used in adjustment are the same across studies. In fact this is far from the case, as is shown in Table II which gives odds ratios from raw data, and published figures given as 'adjusted' in various ways for covariates.
These adjustments, when given in the literature, have gone Overall, therefore, we have chosen as have all other reviews to work with the raw data.
We have also not included the three existing cohort studies of Hirayama (1981; , Gillis et al. (1984) or Garfinkel (1981) . The Gillis study is too small to influence the results. With the other two major studies, there is a substantial question as to whether to use raw data or age-adjusted data. The age-adjusted results in Garfinkel (1981) are 1.18 with a CI of (0.90, 1.54), a huge increase over the raw result of 0.53 with a 95% CI of (0.38, 0.73). There are a number of ways of age-adjusting the Hirayama data (cf Ahlborn & Uberla, 1988; Tweedie (submitted) ), and the latter version of this gives a value of 1.15 as opposed to the value for nonadjusted figures of 1.36 with a 95% CI of (0.95, 1.96).
These are wide variations, and as with the case-control studies in Table II Table II we have therefore omitted them here, although this is not material as the age-adjusted values do not alter the overall conclusion of our analysis.
Levels of significance
The inclusion of new studies has changed the point estimate from the combined analysis from 1.42 in the EPA Draft Review (1990) to 1.17, although this is still, on the basis of the variance from the combined analysis, an estimate which is significant at over the 99% level.
As noted in the EPA Draft Review (1990), one can also carry out a non-parametric test of the significance of the data. Figure 1 shows these odds ratios in descending order, with the 95% confidence intervals from Table I . The sign test on these studies also indicates that, since only seven of 26 studies give values below 1.00, there is also a significant rejection of the hypothesis of no association at the 99% level on this non-parametric basis.
Moreover, as in previous studies we find a value from the combined analysis which is still noticeably (if no longer significantly) above that from the most recent evaluations of biochemical marker data.
However, as observed by Wald et al. (1986) , this significance may be due to differential misclassification, and the adjustments in the previous section take account of this. We Figure 1 Relative risks of case control studies of females.
must then make a corresponding adjustment of the confidence interval in this method. The standard approach has been to adjust the confidence limits themselves by the same amount, i.e. to propose a 95% CI of (0.92, 1.14) based on Table I . This is almost certainly tighter than is warranted, since many of the adjusting figures are themselves open to error: see Mantel (1990) . Indeed, one could well use the results of recent studies, and the range of risks reported, as support for the view that the previously reported results were less accurate than the published CIs would indicate. However, even at these levels the meta-analysis shows the current RRETS to be insignificantly raised at the 5% level. If the correction of 0.12 is applied to the individual estimates, the adjustment to Figure 1 shows this also implies that the number of positive results is no longer significant at the 95% level using the sign test, whilst changing the individual confidence intervals in this way leaves only 7.5% of the results significant at the 5% level, which is also very consistent with a random effect. There is clearly more work needed to develop statistical methods for analysing this type of adjustment method, since the interpretation of the statistical significance of the adjusted data is now at a very subjective level.
Discussion
This paper addresses two questions of on-going importance, not only in the assessment of the relationship between ETS and occurrence of lung cancer, but also in the methodology of evaluation of results which are inherently highly variable and hard to assess.
The first is in the actual level of relative risk to be ascribed to ETS. It has been argued (Wald et al., 1991b ) that '. . . passive smoking is a low dose exposure to a mixture of substances that, at a high dose, is one of the best documented and most potent causes of human cancer.' This biological plausibility is of course the rationale for seeking to assess, by a number of means, whether the exposure incurred by nonsmokers does lead to a substantially increased relative risk, and if so what the level is. It has therefore caused some considerable confusion when two apparently valid approaches to the problem give results which have seemingly differed by an order of magnitude, and where to date the last word has been the somewhat pessimistic statement by Wald et al. (199ib) that it is '. . . not reasonable to expect a close quantitative consistency . . .' between the two, and that given the uncertainties in both methods '. . . it is remarkable that the cotinine levels and the risk estimate [from epidemiological studies] are as concordant as they are'.
There are of course very many difficulties and assumptions in the meta-analysis method, especially in the combining of epidemiological data. It can be criticised because of the differences in the studies that are being put together: there is no clear reason to believe that exposure to ETS in the United Sates is the same exposure as in Asia, for example, nor that the exposure for males is the same as for females. There is also the possibility that negative studies may be omitted (Chalmers, 1988) , leading to an overestimate based on selective inclusion of positive studies and omission of negative studies. There are well-accepted biases due to misclassification in individual studies, and although the Wald technique in Section 3 is now used routinely to adjust for these, it can still be argued (cf Lee, 1991a,b) that the study results are even more biased and the corresponding meta-analysis estimate is too high.
But there are also difficulties and assumptions in the biological marker method. The argument assumes that excess risk is linearly related to cotinine levels: this both assumes that cotinine is an accurate quantitative measure of carcinogen intake if any, and moreover that it is linearly related to the results of such carcinogen intake. It also relies on the current levels of cotinine (which indicate nicotine intake over the past 2-5 days) as being accurate estimates of the background and foreground exposure in the never-smokers over their whole past history. Given that lung cancers are not a product of short term exposures, this entails a major assumption about the relative risks, and stability of those risks, over long time periods.
Repace and Lowry (1990, Section 3) provide a good discussion of the benefits and dangers inherent in using cotinine to evaluate risk, but conclude that several authorities have found it an 'adequate basis for exposure assessment purposes'. It is somewhat surprising, then, that studies such as the NRC Report (1986) or Repace and Lowry (1990) adopt the epidemiologically based value for the overall relative risk to females for exposure to ETS, rather than the values derived from cotinine arguments.
The arguments for its rejection seem to be rather flimsy. Darby and Pike (1989) , p. 338) feel that 'it may simply be that cotinine is not an adequate measure of the exposure of non-smokers to the carcinogenic components of cigarette smoke'. Repace and Lowry (1990, p. 31) state that the 'exposure-response relationship was found to be inconsistent with the epidemiology of passive smoking, and was abandoned' in favour of other phenomenological approaches.
Despite this rejection of the cotinine argument for assessing the overall relative risk of exposure to ETS, it nonetheless continues to be used to make major adjustments for 'background exposure' bias in the review papers cited above, with an increase of virtually 50% in excess risk estimates based on the biochemical argument marker as in Section 3. The logic for this acceptance of cotinine in one part of the analysis and its rejection in another is hard to support.
In this paper we have shown that, using the current published studies of lung cancer and its association with exposure to ETS, there is no need to reject either approach because of the difference in results found.
We have shown that the range of estimates of 1.03-1.10 for the relative risk for exposure to ETS, as calculated by the biological marker method in Section 2, is almost identical with the best estimates from combined analysis of current epidemiological studies given in Section 3, provided one accepts the level of bias indicated for the case-control models in the EPA Draft Review (1990) , and makes a consistent use of the cotinine argument to support a 50% increase in the estimate by taking into account bias from background exposure.
This result is at variance with those in the reviews to date, and is some five to 10-fold weaker than the estimate in the EPA Draft Review (1990) . The methodology here is identical: the only difference is in the addition of a number of new studies.
What could cause such a change in estimates? Formally, it is because the more recent studies include some large (and hence presumed by the methodology to be more reliable) recent studies with estimates of relative risk below the previous combined estimate. Indeed, a considerable amount of the change is due to the inclusion of the Kabat (1990) , Varela (1987) , and studies, although in the other direction the Sobue et al. (1990) and Fontham (1991) studies provide a higher estimate.
Such oscillating outcomes can be confusing, and metaanalysis properly used should enable a clearer overview of the true picture. The second contribution of this paper is to indicate the caution that must be used in setting up such analyses, and to caution against over-interpreting the point estimates from the meta-analysis method. Our point estimate (prior to adjustment for the two types of misclassification) is 1.17 and this seems much lower than the 1.42 of the EPA Draft Report (1990) . But the 95% confidence intervals for these estimates are (1.06, 1.28) and (1.24, 1.63) respectively, and although this indicates that the results of new studies are overall below what might have been expected, they are certainly not giving a total different picture.
More substantially, however, the analysis we give shows clearly the need to include all studies to gain an accurate picture of the overall risk ratio.
There are still some serious methodological questions about meta-analysis in the presence of such a difficult to measure exposure as ETS, especially in the presence of differential misclassification. Mantel (1990) has argued that the very low levels of excess risk reported in studies of ETS and lung cancer are in the region where epidemiological studies can never establish excess risk estimates significantly above zero. Certainly, the contribution of random error at the current state of analysis is not at all clear.
For this reason it is important to develop other techniques which might help establish a figure with greater accuracy. More and better controlled studies help to do this, but so do indirect inferential methods such as the cotinine marker approach. It is therefore of considerable value that the different approaches appear to be reconcilable, rather than leaving open a subjective judgement of which to accept.
